Related Experiment Video
Updated: Jun 21, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Cystic fibrosis care in Chile
Hector H Gutierrez1, Ignacio Sanchez, Daniel V Schidlow
1Division of Pulmonary Medicine, Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama 35233, USA. hgutierrez@peds.uab.edu
Cystic fibrosis (CF) care in Chile and Latin America faces challenges like underdiagnosis and limited resources. Improving outcomes requires centralized centers of excellence, quality initiatives, and national data registries for better patient survival and research participation.
Area of Science:
- Medical Research
- Public Health
- Healthcare Systems
Background:
- Cystic fibrosis (CF) has historically been underdiagnosed and undertreated in Latin America, including Chile.
- Recent healthcare reforms in Chile provide an opportunity to reassess and improve CF care delivery.
- Existing data limitations hinder a comprehensive evaluation of current CF patient care in the region.
Purpose of the Study:
- To describe the evolution of cystic fibrosis care in Chile.
- To identify opportunities for improving outcomes in CF patients.
- To analyze obstacles to optimal CF care in Latin America.
Main Methods:
- Review of recent healthcare reforms in Chile.
- Analysis of available data on the CF patient population.
- Identification of challenges in CF care delivery.
Main Results:
- CF patient population characteristics are presented using recent data.
- Significant obstacles to optimal CF care include lack of professional expertise, patient dispersion across healthcare systems, and limited laboratory infrastructure.
- Despite economic growth, national health indices do not fully reflect CF care quality.
Conclusions:
- Centralizing CF care in centers of excellence with "best practices" is crucial.
- Implementing quality-improvement initiatives and national data registries can enhance patient survival and reduce morbidity.
- These strategies will facilitate greater participation of Latin American CF patients in multicenter clinical research.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

